Cliniphar Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024
Cash & Equivalents	1,440	1,142	1,193
Cash & Short-Term Investments	1,440	1,142	1,193
Cash Growth	26.10%	-4.28%	-
Receivables	124	131	105
Inventory	288	289	187
Other Current Assets	82	64	67
Total Current Assets	1,934	1,626	1,552
Property, Plant & Equipment	26	32	17
Long-Term Investments	516	881	575
Other Intangible Assets	61	75	89
Long-Term Deferred Tax Assets	61	45	45
Other Long-Term Assets	2	3	1
Total Assets	2,600	2,662	2,279
Accounts Payable	19	16	11
Accrued Expenses	2	-	-
Short-Term Debt	100	100	100
Current Portion of Long-Term Debt	579	379	101
Current Income Taxes Payable	-	7	-
Other Current Liabilities	200	93	61
Total Current Liabilities	900	595	273
Long-Term Debt	356	936	1,020
Long-Term Leases	-	-	1
Other Long-Term Liabilities	100	115	117
Total Liabilities	1,356	1,646	1,411
Common Stock	10	10	10
Additional Paid-In Capital	6	6	6
Retained Earnings	1,229	1,068	878
Comprehensive Income & Other	-1	-68	-26
Shareholders' Equity	1,244	1,016	868
Total Liabilities & Equity	2,600	2,662	2,279
Total Debt	1,035	1,415	1,222
Net Cash (Debt)	405	-273	-29
Net Cash Per Share	405.00	-273.00	-29.00
Filing Date Shares Outstanding	1	1	1
Total Common Shares Outstanding	1	1	1
Working Capital	1,034	1,031	1,279
Book Value Per Share	1244.00	1016.00	868.00
Tangible Book Value	1,183	941	779
Tangible Book Value Per Share	1183.00	941.00	779.00